Total Payments
$114,249
2024 Payments
$32,999
Companies
41
Transactions
529
Medicare Patients
1,503
Medicare Billing
$234,578
Payment Breakdown by Category
Other$61,725 (54.0%)
Consulting$30,265 (26.5%)
Food & Beverage$14,900 (13.0%)
Travel$6,564 (5.7%)
Research$500.00 (0.4%)
Education$294.91 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,725 | 41 | 54.0% |
| Consulting Fee | $30,265 | 14 | 26.5% |
| Food and Beverage | $14,900 | 435 | 13.0% |
| Travel and Lodging | $6,564 | 30 | 5.7% |
| Unspecified | $500.00 | 1 | 0.4% |
| Education | $294.91 | 8 | 0.3% |
Payments by Type
General
$113,749
528 transactions
Research
$500.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lucid Diagnostics Inc. | $37,854 | 52 | $0 (2024) |
| RedHill Biopharma Inc. | $31,835 | 59 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19,219 | 52 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $14,320 | 31 | $0 (2024) |
| ABBVIE INC. | $2,203 | 83 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,065 | 92 | $0 (2024) |
| Janssen Biotech, Inc. | $1,217 | 37 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $790.06 | 7 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $599.16 | 5 | $0 (2022) |
| Daiichi Sankyo Inc. | $519.68 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,999 | 100 | Lucid Diagnostics Inc. ($17,419) |
| 2023 | $19,129 | 87 | Lucid Diagnostics Inc. ($16,572) |
| 2022 | $18,794 | 108 | RedHill Biopharma Inc. ($12,896) |
| 2021 | $30,718 | 103 | RedHill Biopharma Inc. ($17,976) |
| 2020 | $9,136 | 60 | Takeda Pharmaceuticals U.S.A., Inc. ($7,568) |
| 2019 | $1,459 | 48 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($330.03) |
| 2018 | $1,087 | 15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($267.19) |
| 2017 | $926.54 | 8 | Valeant Pharmaceuticals North America LLC ($237.38) |
All Payment Transactions
529 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $46.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $40.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: LIVER DISEASE | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $48.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $19.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $126.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Lucid Diagnostics Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $36.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $34.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Lucid Diagnostics Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| 11/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $103.96 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial | Lucid Diagnostics Inc. | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 230 | 252 | $81,585 | $27,227 |
| 2022 | 14 | 400 | 637 | $175,229 | $59,516 |
| 2021 | 8 | 351 | 640 | $287,380 | $64,000 |
| 2020 | 14 | 522 | 922 | $382,527 | $83,835 |
Total Patients
1,503
Total Services
2,451
Medicare Billing
$234,578
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 41 | $16,400 | $5,952 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 46 | $13,110 | $4,500 | 34.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $10,460 | $3,969 | 37.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $13,165 | $3,929 | 29.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 47 | 52 | $11,210 | $3,902 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,990 | $3,022 | 30.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $7,250 | $1,954 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 107 | $30,405 | $11,569 | 38.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 79 | $17,385 | $6,866 | 39.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 33 | $14,025 | $5,560 | 39.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 89 | $13,360 | $5,397 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $14,550 | $5,397 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 31 | $12,400 | $4,835 | 39.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 50 | 54 | $18,060 | $4,328 | 24.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 19 | 19 | $13,480 | $3,717 | 27.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $7,560 | $2,799 | 37.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $16,730 | $2,726 | 16.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 13 | 84 | $6,720 | $2,696 | 40.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $5,349 | $1,976 | 36.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 13 | $3,685 | $1,028 | 27.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 19 | $1,520 | $621.76 | 40.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 74 | 250 | $100,220 | $22,090 | 22.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 62 | 74 | $44,200 | $12,589 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 114 | $31,043 | $12,260 | 39.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 47 | 98 | $29,400 | $6,024 | 20.5% |
About Dr. Seper Dezfoli, M.D
Dr. Seper Dezfoli, M.D is a Gastroenterology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1104159383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seper Dezfoli, M.D has received a total of $114,249 in payments from pharmaceutical and medical device companies, with $32,999 received in 2024. These payments were reported across 529 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($61,725).
As a Medicare-enrolled provider, Dezfoli has provided services to 1,503 Medicare beneficiaries, totaling 2,451 services with total Medicare billing of $234,578. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Beverly Hills, CA
- Active Since 09/07/2009
- Last Updated 04/01/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104159383
Products in Payments
- Talicia (Drug) $31,767
- MOTEGRITY (Drug) $18,711
- VOQUEZNA (Drug) $14,320
- ESOCHECK CCD CELL COLLECTION DEVICE (Device) $3,599
- XIFAXAN (Drug) $1,460
- STELARA (Biological) $1,300
- ZEPOSIA (Drug) $930.98
- SKYRIZI (Biological) $738.30
- TRULANCE (Drug) $656.24
- INJECTAFER (Drug) $519.68
- Humira (Biological) $509.31
- FibroScan (Device) $391.14
- LINZESS (Drug) $344.88
- HUMIRA (Biological) $338.94
- ENTYVIO (Biological) $337.90
- RINVOQ (Biological) $332.00
- TREMFYA (Drug) $300.69
- DUPIXENT (Biological) $237.18
- REMICADE (Biological) $215.71
- IBSRELA (Drug) $181.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Beverly Hills
Dr. Shahab Mehdizadeh, M.d, M.D
Gastroenterology — Payments: $179,492
Gastroenterology $179,492
Dr. Benjamin Basseri, M.d, M.D
Gastroenterology — Payments: $41,181
Gastroenterology $41,181
Dr. Dale Prokupek, Md, MD
Gastroenterology — Payments: $23,740
Gastroenterology $23,740
Dr. Leo Treyzon, M.d, M.D
Gastroenterology — Payments: $20,829
Gastroenterology $20,829
Dr. Jonathan Ellis, Md, MD
Gastroenterology — Payments: $19,725
Gastroenterology $19,725
Dr. Robert Mocharla, M.d, M.D
Gastroenterology — Payments: $8,280
Gastroenterology $8,280